Sulfuric Acid

Sulfuric Acid

SCHEMBL866069

Cc1cc2nc3ccc(Nc4ccccc4)cc3[n+](-c3ccccc3)c2cc1N.O=S(=O)([O-])O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
GNG2 P59768 1/20 0.42
GNB1 P62873 1/20 0.42
SNCA P37840 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
NLRP3 Q96P20 1/20 0.38
CASP7 P55210 2/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34
RECQL P46063 1/20 0.34
HIF1A Q16665 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20555452 0.92 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL14281484 0.87 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Sulfuric Acid SCHEMBL16728394 0.82 APAF1 (0.48) ENPP2ALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL20969281 0.81 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL20969282 0.81 KMT2A (0.46) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Hydrochloric Acid SCHEMBL20969312 0.81 KMT2A (0.46) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Sulfuric Acid SCHEMBL519200 0.81 ALDH1A1 (0.42) ENPP2ALDH1A1CYP1A2CYP2D6GNG2
Sulfuric Acid SCHEMBL865288 0.80 NPC1 (0.49) ENPP2ALDH1A1CYP1A2CYP2D6L3MBTL1
Hydrochloric Acid SCHEMBL15265 0.78 NPC1 (0.47) ALDH1A1L3MBTL1NPC1RAB9ANLRP3
SCHEMBL10005072 0.78 ALDH1A1 (0.55) ENPP2ALDH1A1CYP1A2CYP2D6GNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619244-B1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN INC (US) 2018-11-14 EP claimed
US-9040700-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2015-05-26 US claimed
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds MACDERMID ACUMEN, INC. (US) 2014-06-12 US claimed
US-8735580-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2014-05-27 US claimed
EP-2619244-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MacDermid Acumen, Inc. (US) 2013-07-31 EP claimed
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US claimed
WO-2012040417-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN, INC. (US) 2012-03-29 WO claimed
EP-2619244-B1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN INC (US) 2018-11-14 EP disclosed
US-9040700-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2015-05-26 US disclosed
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds MACDERMID ACUMEN, INC. (US) 2014-06-12 US disclosed
US-8735580-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2014-05-27 US disclosed
EP-2619244-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MacDermid Acumen, Inc. (US) 2013-07-31 EP disclosed
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
US-20120077956-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
WO-2012040417-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN, INC. (US) 2012-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, CHRM5 ENPP2 2999/4885ALDH1A1 2815/4885CYP1A2 1412/4885
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, H1-5 ENPP2 2827/4885ALDH1A1 2671/4885CYP1A2 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.